Early Adjuvant Chemotherapy After Surgery May Reduce Risk of Relapse

Share this content:
Shorter time to initiation of adjuvant chemotherapy may reduce risk of relapse and improve clinical outcomes in breast cancer.
Shorter time to initiation of adjuvant chemotherapy may reduce risk of relapse and improve clinical outcomes in breast cancer.

Shorter time to initiation of adjuvant chemotherapy after definitive surgery may reduce risk of relapse and improve clinical outcomes in patients with highly-proliferating early breast cancer, according to a study published in the European Journal of Cancer.

In a phase 3 trial, Italian researchers led by Alberto Farolfi, MD, randomly assigned 921 patients with early breast cancer who had rapidly-proliferating tumors to receive chemotherapy with or without anthracyclines. They wanted to evaluate the optimal time interval to commence chemotherapy after surgery in these patients.

With a median follow-up of 105 months, they used the Kaplan-Meier method to determine disease-free survival, overall survival, and 95 percent confidence intervals.

The researchers found that prolonged time to initiation resulted in significant increase in risk of relapse. Upon time-dependent receiver-operating characteristic (ROC) curve analysis, they found that the best cut-off threshold for time to initiation of adjuvant chemotherapy and longer overall survival was 7 weeks, with 8-year overall survival found in 88% of patients with a time to initiation of less than 7 weeks and 78% in other patients.

RELATED: Mammogram Facilities, Tumor Biology Linked to the Racial Disparity in Breast Cancer

In addition, they found that time to initiation, tumor size and nodal involvement remained significantly associated with disease-free survival using a backward elimination procedure.

“Our results confirm that a shorter time to initiation of adjuvant chemotherapy may reduce relapses and possibly also improve clinical outcomes in patients with highly proliferating early breast cancer,” the authors concluded.

Reference

  1. Farolfi A, Scarpi E, Rocca A, et al. Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer. European Journal of Cancer. doi: http://dx.doi.org/10.1016/j.ejca.2015.07.003. July 20, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs